Paulo J. Oliveira is a Principal Investigator with “Agregação” at the Center for Neuroscience and Cell Biology,
University of Coimbra (UC), Portugal. He is the current leader of the “Mitochondria, Metabolism and Disease”
group and of the MitoXT: Mitochondrial Toxicology and Experimental Therapeutics laboratory. He completed
his PhD in Cellular Biology at UC in 2003. After completing his PhD, Paulo Oliveira spent more than three
years working at the University of Minnesota Medical School, Duluth, USA, where he collaborated with several
researchers and contributed to the publication of several peer-reviewed manuscripts. Paulo Oliveira's current
research focuses on mitochondrial metabolism, namely alterations resulting from aging and lifestyle-related
diseases, and on investigating strategies to preserve mitochondrial function across the lifespan for a healthy
aging. Paulo has over 350 peer-reviewed papers, is currently the coordinator of the EU-funded projects PAS
GRAS and Excelscior, and has maintained a consistent primary role in the organization of national and
international scientific meetings, including the International Courses in Toxicology (2005-2010), Annual
Meeting of the European Society for Clinical Investigation (2013 and 2019, Coimbra, Portugal), the 2014
Meeting of the Portuguese Biochemical Society, and FEBS Advanced Lecture Courses in Oncometabolism
(2017 and 2019). Paulo Oliveira was also President of the European Society for Clinical Investigation (2019
2022) and is a reviewer for more than 40 scientific journals and over 10 different funding agencies, including
the European Commission (Research Executive Agency) and the Portuguese Foundation for Science and
Technology. Since 2020, Paulo is Vice-President of the CNC – Center for Neuroscience and Cell Biology, UC,
Portugal.. As an entrepreneur, Paulo is also co-founder of the start-up MitoTAG, which develops
mitochondria-directed antioxidant with applications in cosmetics and human health, and is co-inventor in
several patents.